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Platypnea orthodeoxia (PO) is an infrequent condition of dyspnea with hypoxemia, increased by adopting an upright position and
is relieved in decubitus. This condition may occur in patients with hidden intracardiac shunts, usually across a persistent foramen
ovale (PFO). The incidence of PFO in general population is quite common, around 27%; however, the concurrent presentation with
PO, especially in acute refractory respiratory failure, is extremely rare. PFO closure in this setting is still the treatment of choice with
significant improvement or complete resolution of symptoms after closure with an overall periprocedural complication in the first
24 hours of approximately less than 5%. A transient ST-segment elevation in the inferior leads is present in extremely rare occasions
and most likely is induced by either an air embolism or a mechanically provoked spasm of coronary arteries. We report a case of an
83-year-old woman in acute hypoxic and refractory respiratory failure in whom PO was identified, most likely induced by a hidden
PFO. The patient underwent percutaneous transcatheter closure and developed immediate chest pain, transient hemodynamic
instability, and ST-segment elevation in the inferior leads; nevertheless, our patient recovered completely with rapid resolution of
respiratory failure with no adverse clinical sequelae.

1. Introduction
Platypnea orthodeoxia (PO) is an uncommon presentation of an underlying disorder consisting of hypoxemia
and dyspnea upon assuming an upright position and is
relieved by decubitus [1]. This condition can be secondary
to an intracardiac shunt, a pulmonary vascular shunt,
or a ventilation–perfusion mismatch. A right-to-left shunt
through a persistent foramen ovale (PFO) may produce a
significant desaturation of arterial blood when the patient
changes from decubitus to a sitting or standing position
[2]. Most PFOs are not expected to cause sufficient rightto-left shunting to elicit hypoxemia due to higher left atrial
pressure and greater compliance of the right atrium and
ventricle. A spontaneous or induced increase in pulmonary
artery pressure (PAP) may produce a sufficient increase in the

right atrial pressure to promote a right-to-left shunt ensuing
hypoxemia [3]. The incidence of PFO is quite common in
general population with an overall incidence of 27% and with
a mean diameter of 4.9 mm; however, the concurrent presentation with PO in the context of acute refractory respiratory
failure is extremely rare [4, 5]. Transient periprocedural
complications in the first 24 hours following PFO closure
are uncommon and the pathophysiological mechanisms have
not been yet described. We present a case of a patient in
acute hypoxic and refractory respiratory failure exhibiting
PO due to a right-to-left shunt through a previously undiagnosed PFO. The patient was treated with percutaneous
transcatheter PFO closure and presented chest pain, transient
hemodynamic instability, and ST-segment elevation after this
procedure. The patient recovered completely and there were
no adverse clinical sequelae.
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Figure 1: Agitated saline contrast study showing (a) 4 chambers prior contrast infusion. (b) Agitated saline entering the RA. (c) and (d)
Arrows demonstrating right-to-left shunt into the LA and LV. RV: right ventricle; LV: left ventricle; RA: right atria; LA: left atria. Arrows
throughout indicate direction of the agitated saline flow.

2. Case Report
An 83-year-old woman with diabetes mellitus type 2, essential
hypertension, and hyperlipidemia came to the emergency
department with history of 3 days of progressive cough and
shortness of breath and 1 day of pressure-like chest pain and
anxiety. She did not have a history of smoking. Initial physical
examination revealed a patient in severe respiratory distress.
Oxygen saturation (O2 Sat) was 94% with a nonrebreather
mask at 80% FIO2 and cardiovascular examination revealed a
soft 2/6 holosystolic murmur located in the left sternal border,
without gallops. Diffused rales were auscultated in both lung
fields. The rest of examination and vital signs were unremarkable.
ABG analysis showed acute respiratory alkalosis with
moderate hypoxemia and laboratory panels including complete blood count, electrolytes, and troponins were within
normal limits. Electrocardiogram (ECG) was normal; chest
X-ray and chest computed tomography angiography exhibited diffuse interstitial ground-glass opacities bilaterally suggestive of pulmonary edema and no filling defects ruling
out pulmonary embolism. The patient was transferred to
the Intensive Care Unit for close monitoring and treated
with bilevel positive airway pressure and intravenous diuretics demonstrating a slight clinical improvement; however,
hypoxemia persisted and orthodeoxia was identified. O2 Sat

decreased significantly from 91% in decubitus to 86% when
adopting a sitting position.
Echocardiography (TTE) showed ejection fraction
50–55% with RVSP 63 and a slightly positive agitated saline
contrast test (ASCT) consistent with an interatrial shunting.
Transesophageal echocardiography (TEE) was performed
showing a positive interatrial communication; nevertheless,
images were inconclusive to further evaluate and to determine the precise location of this interatrial defect due to
suboptimal echocardiographic images. Cardiac magnetic
resonance was not definitive for the presence of an atrial
septal defect. Coronary computed tomography angiography
was recommended and exhibited mild nonobstructive
coronary atherosclerosis and nonspecific pulmonary vascular
congestion with no evidence of atrial septal defect or an
unroofed coronary sinus.
Decision was made to clarify the diagnosis with a right
heart catheterization and intracardiac echocardiography,
which revealed an intact interatrial septum with an evident
PFO. An absent “step up” in saturation ruled out a left-toright shunt. A TTE with ASCT was repeated and performed
in reversed Trendelenburg position demonstrating a strongly
and obvious right-to-left shunt through a PFO (Figure 1).
The defect was emergently closed using an 18 mm Amplatzer
Cribriform Septal Occluder (Figure 2). The patient expressed
sudden severe chest pain after the procedure. ECG exhibited
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Figure 2: Fluoroscopic positioning and deployment of 18 mm
Amplatzer Cribriform Septal Occluder.

ST-segment elevation in leads II, III, and aVF, followed by a
significant decrease in the mean arterial pressure. Bedsides
ultrasonography showed proper device position and no
cardiac tamponade was noted. Intra-aortic balloon pump was
inserted for hemodynamic support and vasopressors were
started. A right coronary artery air embolism was suspected;
therefore a coronary angiogram was performed and showed
no abnormalities. Left ventricular angiogram and aortogram
were within normal parameters.
The patient stabilized with resolution of chest pain and
normalization of the ECG changes and became normotensive. A TTE was repeated showing normal left ventricle function, no evidence of pericardial effusion, and no wall motion
abnormalities. The patient remained hemodynamically stable, vasopressors were weaned off, and the intra-aortic
balloon pump was removed. The patient experienced a positive outcome with complete resolution of respiratory failure
with low requirements of oxygen therapy. The patient was
discharged to home saturating 98% on room air.

3. Discussion
The exact pathophysiological mechanism of PO is not
well understood; however, it could be explained by several
hypotheses on the basis of positional modifications that favor
a shunting phenomenon through an atrial communication.
These modifications might increase a right-to-left shunt
through a PFO with significant desaturation of arterial blood
when the patient stands up or bends over [6]. PFO size tends
to be enhanced with increasing age, from a mean of 3.4 mm
in the first decade to 5.8 mm in the 10th decade of life [4].
Standing upright might stretch the interatrial communication of the PFO thus allowing more streaming of venous
blood from the inferior vena cava through the defect [7].
Another explanation could be a preferential vena caval blood
flow directed towards the atrial septum during an upright
position, such as in patients with prominent Eustachian
valve. In patients with chronic hypoxemia, low mixed venous
oxygen tension of blood returning to the pulmonary arteries
induces a pulmonary vasoconstriction that increases right
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atrial pressure and it is believed that it could create a greater
gradient of pressures between both atria, supporting a rightto-left shunt through an interatrial communication [8].
PO in the setting of a PFO can be presented with a
concomitant increase in PAP; nevertheless, in some cases in
which a preferential flow phenomenon has been detected,
patients present with normal atrial pressure and PAP but with
severe right-to-left shunt [9]. These anatomic abnormalities
together with a pulmonary hypertension could deteriorate
in an acute, refractory, and dangerous manner a patient’s
oxygenation status if the diagnosis of a PFO and immediate
treatment is not considered. It is imperative to select an initial
imaging test for this condition and Muratori et al. in a recent
study established that the sensitivity of TTE with ASCT can
be improved using provocative measures like valsalva maneuvers [10]. TEE is the gold standard technique for the visualization of atrial septal anatomy, but there might be some technical challenges in eliciting an adequate increase in right atrial
pressure during imaging due to varying degree of patient
sedation and participation [11]. In our patient, no positional
changes were assessed during imaging testing, the strength
of the right-to-left shunt through the PFO could have been
physiologically reduced during decubitus position and consequently extremely difficult to detect. Transcranial Doppler
is another imaging tool with high sensitivity that can be used
to screen and quantitate shunt severity; unfortunately, this
modality is unable to differentiate cardiac from pulmonary
shunts [12].
Percutaneous transcatheter closure is still the treatment
of choice for PFO presenting with PO. Guérin et al. demonstrated in 78 patients an immediate increase in saturation
and significant decrease in dyspnea following percutaneous
occlusion of PFO [13]. A recent study confirmed that 64.8%
of patients presenting with PFO and PO had improvement
or complete resolution of their dyspnea after transcatheter
closure [14]. There have been some studies that have identified
that the overall periprocedural complications in the first 24
hours in 276 patients following PFO closure were of 4%. A
transient (<3 min) ST-segment elevation, in the inferior leads
was present in 1.4%, most likely induced by either an air
embolism or a mechanically induced spasm of the coronary
arteries [15]. Some authors have reported similar transient
events during transseptal catheter procedures such as atrial
fibrillation ablation and have hypothesized that following
manipulation of the interatrial septum could stimulate left
atrial ganglion plexuses causing an imbalance in autonomic
innervation, which leads to coronary artery spasm and STsegment elevation [16]. A recent multicenter, randomized,
superiority trial evaluated the procedural complications from
PFO closure and demonstrated that atrial fibrillation was only
present in 5.9% in comparison to the nonintervention group
[17]. Other potential complications of percutaneous device
placement can include access difficulties, device embolisation
or malposition, pericardial effusion secondary to perforation
of the atrium or pulmonary veins, or device thrombus
formation [18]. There is no supporting data in literature
about sudden chest pain immediately after transcutaneous
closing of PFO. A small number of patients have had device
removal due to chest pain, presenting late after implantation,
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of which 18% were associated with nickel allergy present in
Amplatzer devices [19]. This would not explain the immediate
hemodynamic collapse seen in our patient.
We suspect that the transient hemodynamic instability
and ST-segment elevation were probably due to catheter
manipulation of the atrial septum or a small air embolism to
the right coronary artery, sufficient enough to induce an autonomic imbalance and a possible coronary artery vasospasm.
Despite this brief episode of instability, the patient’s respiratory failure and chest pain resolved completely and there were
no adverse clinical sequelae.

4. Conclusion
A PFO as the main cause of acute hypoxic respiratory failure
is rare and usually it is not sufficient to cause right-to-left
shunting to elicit desaturation. Refractory hypoxemia associated with positional anatomic modifications might favor
a shunting phenomenon through an atrial communication.
If orthostatic desaturation is detected, it should warrant
further investigation. Patients with refractory hypoxemia
and suspicious echocardiographic findings should prompt an
evaluation with positional changes to facilitate identification
of a PFO as a potentially treatable cause of respiratory failure.
A noninvasive, safe, and initial diagnosis can be performed
by TTE using ASCT moving the patient from a supine
to an upright position or by using a tilt-table. Therefore,
the shunt can be localized at the atrial level and directly
visualized. The transient hemodynamic compromise seen in
our patient appeared to be a complication of PFO closure
and more studies should be performed to elucidate the exact
pathophysiologic mechanism. Physicians should be aware of
this transient immediate complication after PFO closure.
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